Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.19.1
Accrued Expenses
3 Months Ended
Mar. 31, 2019
Accrued Liabilities, Current [Abstract]  
Accrued Expenses and other payables

8. Accrued Expenses


Accrued expenses consist of the following:


 

 

March 31,
2019

 

December 31,
2018

 

Accrued clinical trial expenses

 

$

719,116

 

$

919,750

 

Compensation and related benefits

 

 

102,490

 

 

628,147

 

Patent fees

 

 

45,000

 

 

40,000

 

Deferred rent

 

 

—

 

 

7,854

 

Other expenses

 

 

82,300

 

 

82,300

 

 

 

$

948,906

 

$

1,678,051